Topics

Companies Related to "Atopic Dermatitis Therapeutics Southeast Asia Markets 2024 Growth" [Most Relevant Company Matches] [Advanced Search Results] RSS

12:22 EDT 3rd April 2020 | BioPortfolio

Here are the most relevant search results for "Atopic Dermatitis Therapeutics Southeast Asia Markets 2024 Growth" found in our extensive corporate database of over 50,000 company records.

Showing "Atopic Dermatitis Therapeutics Southeast Asia Markets 2024 Growth" Companies 1–25 of 6,700+

Extremely Relevant

Atopix Therapeutics Ltd

Atopix Therapeutics Limited is a privately held, clinical-stage, biopharmaceutical company based in Oxford, UK, with an innovative approach to allergy. The company is developing a novel class of oral anti-allergic medicines, called CRTH2 antagonists, to treat atopic dermatitis, asthma and allergic rhinitis. Its lead candidate is currently being studied in a Phase 2 clinical trial for severe atop...


Dermavant

Dermavant Sciences, a subsidiary of Roivant Sciences, is a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative therapeutics in immuno-dermatology. Dermavant’s focus is to develop therapies that have the potential to address high unmet medical needs while driving greater efficiency in research and clinical development. The company’s robust medi...

Immune Pharmaceuticals Inc.

Immune Pharmaceuticals Inc. (NASDAQ:IMNP) is dedicated to alleviating the burden of patients suffering from autoimmune diseases by developing novel immunotherapeutic agents. Immune's lead product candidate, bertilimumab, is in Phase 2 clinical development for bullous pemphigoid, an orphan autoimmune dermatological condition, and for ulcerative colitis. Oth...


Relevant

Ziarco Pharma Ltd.

Ziarco is a clinical-stage biotechnology company developing innovative therapeutics targeting dermatological and inflammatory diseases. ZPL-389, the Company’s lead compound, is an oral histamine H4 receptor antagonist, currently in two Phase 2a studies: the first in atopic dermatitis is fully recruited and will read out in Q2 2016; and the second has ...

Provectus Biopharmaceuticals, Inc.

Provectus Biopharmaceuticals specializes in developing oncology and dermatology therapies. Its novel oncology drug PV-10 is designed to selectively target and destroy cancer cells without harming surrounding healthy tissue, significantly reducing potential for systemic side effects. Its oncology focus is on melanoma, breast cancer and cancers of the liver....

Provectus Pharmaceuticals, Inc.

Provectus Pharmaceuticals specializes in developing oncology and dermatology therapies. Its lead oncology agent, PV-10, is designed to selectively target and destroy cancer cells without harming surrounding healthy tissue, significantly reducing potential for systemic side effects. Its oncology focus is on melanoma, breast cancer and metastatic liver cance...

Sinclair Pharma Plc

Sinclair Pharma plc is an international specialty pharmaceutical company focused on the sourcing and acquisition of innovative products, registration and commercialisation of those products.Sinclair currently focuses in dermatology, oral health and ophthalmology. The company is experiencing strong sales growth, particularly for its main products Aloclair (mouth ulcers), Atopiclair (eczema/atopic d...

Arbor Pharmaceuticals

Arbor Pharmaceuticals, headquartered in Raleigh, North Carolina, is a specialty pharmaceutical company focused exclusively on the growing pediatric market. The company intends to become the leading pediatrics-focused pharmaceutical company by actively licensing, developing and commercializing late-stage products for significant pediatric conditions. Arbor currently markets three nonantibiotic prod...

Ceragenix Pharmaceuticals, Inc.

Ceragenix Pharmaceuticals, Inc. is a medical device company focused on infectious disease and dermatology. The Company has two base technology platforms; Ceragenins™ or (“CSAs”) for treatment of infectious disease and Barrier Repair for the treatment of dermatological disorders including atopic dermatitis, neonatal skin disorders and others. ...

NKT Therapeutics, Inc.

NKT Therapeutics, Inc. is a privately held biotechnology company focused on developing therapeutics based on unique immune cells called natural killer T (NKT) cells. The company’s mission is to use its expertise to develop a pipeline of first-in-class NKT-based therapeutics to treat autoimmune and inflammatory diseases, cancer, infectious diseases, and ...

Akaal Pharma Pty Limited

Akaal Pharma is a private clinical-stage, Australian biotech company focused on advancing the clinical development of its internally discovered topical and oral small molecule drug candidates for treating inflammatory, immune and vascular diseases specifically atopic dermatitis, psoriasis, arthritis, pain, nephropathy, retinopathy, multiple sclerosis, ulce...

Biofrontera AG

Biofrontera AG is a biopharmaceutical company specializing in the development of drugs for the treatment of dermatological and inflammatory diseases. The Company has three product candidates in clinical development for four different clinical indications. The most advanced products are BF-200 ALA (Phase IIb/III) for actinic keratosis and condyloma; and BF-derm 1 (Phase II) for chronic, antihistami...

Paloma Pharmaceuticals, Inc.

Paloma Pharmaceuticals, Inc. is a drug development company with PI3K/Akt/mTOR inhibitors for cancer, ocular diseases (AMD and DR), CNS (epilepsy, Parkinson's, Alzheimer's, Huntington's and Schizophrenia), fibrotic diseases (pulmonary and renal fibrosis), antiviral (HIV, HCV) and skin diseases (psoriasis and atopic dermatitis). Paloma owns the intellectual property relating to a library of novel, p...

Ceragenix Phamaceuticals

Ceragenix Pharmaceuticals Inc. (Ceragenix) is an emerging biopharmaceutical company developing next generation prescription therapies based on its platform of proprietary surface active technologies — skin Barrier Repair Technology (BRT) and a new class of broad spectrum anti-infectives called Ceragenins™. EpiCeram®, is a topical non-steroidal skin care cream based on the research of Dr. Pet...

Azitra Inc.

Azitra, Inc. is a clinical-stage medical dermatology company that combines the power of the microbiome with cutting-edge genetic engineering to treat skin disease. The company was founded in 2014 by scientists from Yale University and works with world-leading scientists in dermatology, microbiology, and genetic engineering to advance its pharmaceutical programs to treat cancer therapy associated ...

Sirbal Ltd.

Sirbal Ltd. was founded by Mr. Nadav Shraibom, a Chinese Herbal Medicine Clinician, with Messrs. Tal Dilian and Eran Steinberg as co-founders. Its mission is to provide safe and efficient treatments for inflammatory diseases. Its first products based on a multi-herbal botanical extract, SIRB-001, clinically establishes clear efficacy and safety in topical ...

PhotoMedex, Inc.

PhotoMedex is a Global Skin Health Solutions™ company that provides integrated disease management and aesthetic solutions through complementary laser and light-based devices, pharmaceuticals and cosmeceuticals. We are a leader in the development, manufacturing and global marketing of dermatology products and techniques focused on advancing cost-effect...

Business Accelerator Network for Southeast Michigan

The Business Accelerator Network for Southeast Michigan is new region-wide network for building and retaining new business in southeast Michigan. Composed of the region's four key business accelerators- Ann Arbor SPARK, Automation Alley, Macomb-OU INCubator, and TechTown, the organization will work collaboratively to share best practices, host events focused on addressing issues and goals that imp...

Devonian Health Group Inc.

Devonian Health Group Inc. is a late stage botanical pharmaceutical corporation with novel therapeutic approaches to targeting unmet medical needs. Devonian's core strategy is to develop prescription botanical drugs from plant materials and algae for the treatment of inflammatory-autoimmune diseases including but not limited to ulcerative colitis and atopi...

Qurient Co. Ltd.

Qurient is a clinical-stage biopharmaceutical company listed in Korea Exchange (KRX 115180). Qurient has two programs in clinical development and one program in the IND enabling stage. Q301 is a topical leukotriene inhibitor for atopic dermatitis in a Phase 2b clinical trial in the United States. Q702 is a Axl/Mer/CSF1R triple inhibitor for immune-oncology...

A. Menarini Asia-Pacific Holdings Pte Ltd

Menarini Asia-Pacific is part of the world’s largest Italian biopharmaceutical company with a heritage since 1886 and over 17,000 employees in more than 100 countries. Here in Asia-Pacific, Menarini has an established presence in 13 key healthcare markets with over 3,000 sales, marketing and support professionals.

Botanix Pharmaceuticals Limited

Botanix Pharmaceuticals Limited (ASX:BOT) is a clinical stage cannabinoid company based in Perth (Australia) and Philadelphia (USA) committed to the development of pharmaceutical products that are underpinned by science and supported by well-controlled randomised clinical trials. The Company’s focus is the development of safe and effective topical treatments for acne, psoriasis, atopic derma...

Immune Pharmaceuticals, Inc.

Immune Pharmaceuticals is a biopharmaceutical company developing novel therapeutic agents for the treatment of immunologic and inflammatory diseases. Our lead program, bertilimumab, is a first-in-class, fully human monoclonal antibody that targets and lowers levels of eotaxin-1, a chemokine that plays a role in immune responses and attracts eosinophils to ...

fOCUS Pharmaceuticals, LLC

fOCUS Pharmaceuticals is a privately held generic and branded pharmaceutical company specializing in the research and development of prescription dermatology products. Our primary focus are in the areas of Psoriasis, Acne Vulgaris, Actinic Keratoses, Atopic Dermatitis, Cutaneous Ulcers and Onychomycosis.Our staff has years of experience in all aspects of the pharmaceutical business. Established in...

Süd-Chemie

Süd-Chemie is a highly-innovative, listed, specialty chemicals company headquartered in Munich. As a specialist in chemistry and physics of surfaces comprising finely distributed inorganic substances, it plays a vital role in customer value-chains. With its two divisions of Adsorbents and Catalysts, the Süd-Chemie Group, which has around 5,100 employees, generates total sales of approx. 933 mill...


More From BioPortfolio on "Atopic Dermatitis Therapeutics Southeast Asia Markets 2024 Growth"

Quick Search

Corporate Database Quicklinks